A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
MBrace Therapeutics
NantCell, Inc.
A2 Biotherapeutics Inc.
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
PureTech
Klus Pharma Inc.
Kineta Inc.
Faron Pharmaceuticals Ltd
Lumos Pharma
Stanford University
National Institutes of Health Clinical Center (CC)
First Affiliated Hospital of Chengdu Medical College
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)